Monica Healthcare
Wireless patch for fetal and maternal monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
NOK10.0m | Grant | ||
| Total Funding | 000k | ||
| GBP | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 115 % | 191 % | (47 %) | 108 % | (45 %) | (47 %) | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (40 %) | 25 % | 144 % | 43 % | 43 % | 13 % | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (45 %) | 17 % | 143 % | 41 % | 40 % | 12 % | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | 25 % | 98 % | 48 % | 83 % | 86 % | - |
Source: Company filings or news article
Related Content
Monica Healthcare, founded in 2005 as a spin-out from the University of Nottingham, develops wearable medical devices for fetal and maternal monitoring. The company originated from research conducted between 1989 and 2002 by Professor Barrie Hayes-Gill and his colleague Professor John Crowe. The venture was established by Professor Hayes-Gill, Dr. Carl Barratt (CEO), and Dr. Jean Francois Pieri (CTO). The motivation for Professor Hayes-Gill's research in this area was deeply personal, stemming from family health tragedies.
The company's core product is the Novii Wireless Patch System, a single-use, peel-and-stick patch that non-invasively monitors fetal heart rate (FHR), maternal heart rate (MHR), and uterine activity (UA). It utilizes abdominal surface electrodes to pick up fetal ECG (fECG), maternal ECG (mECG), and uterine electromyography (EMG) signals. This technology offers expectant mothers greater mobility and comfort during labor compared to traditional belt-based cardiotocograph (CTG) systems. The system consists of the disposable Novii Patch, a reusable Novii Pod that processes the signals and transmits them via Bluetooth, and an interface that connects to existing hospital fetal monitors.
Monica Healthcare operated in the maternal-infant care market, serving midwives, nurses, and expectant mothers in hospitals. Before its acquisition, the company's technology was used at approximately 1,000 sites across North America, Europe, and Asia, impacting over 100,000 patients in 2016. In March 2017, GE Healthcare acquired Monica Healthcare for an undisclosed sum. Prior to the acquisition, GE Healthcare had been the exclusive North American distribution partner for the Novii system since 2015. The acquisition integrated Monica's mobile and digital monitoring solutions into GE Healthcare's maternal-infant care portfolio.
Keywords: maternal-fetal monitoring, wearable medical device, wireless patch, fetal heart rate, maternal heart rate, uterine activity, intrapartum monitoring, obstetric care, fetal ECG, GE Healthcare, Novii Wireless Patch, University of Nottingham spin-out, Carl Barratt, Barrie Hayes-Gill, electromyography, MedTech, maternal care, labor and delivery, patient monitoring, digital health